DarioHealth Targets $95B GLP-1 Market with 79% Member Weight Management Engagement
DarioHealth reports 79% of digital health members use its weight management features, underscoring adoption for its oral GLP-1 behavioral support program. Oral GLP-1s are projected to capture 25% of the $95 billion GLP-1 market by 2030, and DarioHealth aims to boost payer ROI with precision adherence tools and real-time coaching.
1. Growing Demand for Oral GLP-1 Support
Employer and health plan demand for DarioHealth’s digital oral GLP-1 solution is increasing as payers seek to manage rising medication costs and improve real-world outcomes through structured behavioral reinforcement.
2. Member Engagement and Data Insights
DarioHealth’s book of business shows 79% of members use weight management features within its multi-condition platform, underlining strong user adoption and the importance of daily adherence to optimize weight and glycemic results.
3. Behavioral Tools Driving Adherence
The platform’s core tools include a medication cabinet for tracking doses, a grocery scanner to guide food choices and access to personal coaches, all designed to align pharmacotherapy with sustained behavior change.